Raj S. Pruthi, M.D. M.H.A. is Senior Medical Director, Oncology (Prostate Cancer), The Janssen Pharmaceutical Companies of Johnson and Johnson. He is a graduate of Stanford University and received his MD degree from Duke University School of Medicine. Following medical school he completed his residency and post-graduate training at Stanford University. His clinical and research interests are in urologic oncology including bladder, and prostate cancer, and has published over 200 peer review publications in theses areas. In addition to serving as a consultant and reviewer for numerous publications, he was also on the editorial board for several journals including the Journal of Urology, British Journal of Urology, World Journal of Urology, Prostate Cancer and Prostatic Diseases, amongst others. Dr. Pruthi currently serves on a number of institutional, regional, and national teaching and professional capacities, including the American Urologic Associations Guidelines on the Management of Non-muscle Invasive Bladder Cancer, the Bladder Cancer Guidelines Committee of the International Consultation on Urological Diseases, the ABU/AUA Examination Committee, the American College of Surgeons Advisory Council and Chair of the Advisory Council for Urology, the Board of Governors for the American College of Surgeons, and President for the Society of Academic Urology. He has previously served as the inaugural/founding Chair of the Department of Urology at the University of North Carolina at Chapel Hill and as the Chair of the Department of Urology at UCSF. During his time at UNC and UCSF, Dr. Pruthi helped establish wellness programs as well as fostering diversity, equity, and inclusion initiatives. He also established a mentorship program for both trainees and faculty at UNC and UCSF.